Information for "Safety along with tolerability regarding PD1PDL1 inhibitors within aged and weak individuals using advanced types of cancer"
From EECH Central
Basic information
| Display title | Safety along with tolerability regarding PD1PDL1 inhibitors within aged and weak individuals using advanced types of cancer |
| Default sort key | Safety along with tolerability regarding PD1PDL1 inhibitors within aged and weak individuals using advanced types of cancer |
| Page length (in bytes) | 3,457 |
| Page ID | 1348284 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Heightnumber06 (Talk | contribs) |
| Date of page creation | 10:16, 8 April 2024 |
| Latest editor | Heightnumber06 (Talk | contribs) |
| Date of latest edit | 10:16, 8 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
